Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 101
of 6Next
1:

The continuing HIV vaccine saga: naked emperors alongside fairy godmothers.

Smith KA.

Med Immunol. 2005 May 6;4(1):6.

PMID: 15877816 [PubMed - as supplied by publisher]

2:

The HIV vaccine saga.

Smith KA.

Med Immunol. 2003 Feb 14;2(1):1.

PMID: 12628020 [PubMed - as supplied by publisher]

3:

A safe, effective and affordable HIV vaccine--an urgent global need.

Joseph J, Etcheverry F, Alcami J, MarĂ­a GJ.

AIDS Rev. 2005 Jul-Sep;7(3):131-8. Review.

PMID: 16302460 [PubMed - indexed for MEDLINE]

4:

AIDS: is there an answer to the global pandemic? The immune system in HIV infection and control.

Maplanka C.

Viral Immunol. 2007 Sep;20(3):331-42. Review.

PMID: 17931104 [PubMed - indexed for MEDLINE]

6:

The continuing HIV vaccine saga: is a paradigm shift necessary?

Smith KA.

Med Immunol. 2006 May 18;5:2.

PMID: 16709246 [PubMed]

7:

Latest developments in the field of assisted circulation.

Richenbacher WE.

ASAIO J. 2005 Nov-Dec;51(6):xv-xx.

PMID: 16340342 [PubMed - indexed for MEDLINE]

8:

HIV vaccine and pathogenesis update. The 2005 HIV Keystone symposium.

Hardy G.

GMHC Treat Issues. 2005 May-Jun;19(5-6):9-14. No abstract available.

PMID: 16193578 [PubMed - indexed for MEDLINE]

9:

Invited commentary: The scientific basis for stopping polio immunization.

Hull HF, Aylward RB.

Am J Epidemiol. 1999 Nov 15;150(10):1022-5.

PMID: 10568616 [PubMed - indexed for MEDLINE]

10:

Perspectives of HIV vaccine developments.

Ferdinand FJ, Dorner F, Kurth R.

J Virol Methods. 1987 Aug;17(1-2):63-7. Review.

PMID: 3312268 [PubMed - indexed for MEDLINE]

11:

Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India.

Kumar S, Aggarwal P, Vajpayee M, Pandey RM, Seth P.

Vaccine. 2006 Mar 24;24(14):2585-93. Epub 2006 Jan 4.

PMID: 16480792 [PubMed - indexed for MEDLINE]

12:

Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants.

Calarota SA, Weiner DB.

Immunol Rev. 2004 Jun;199:84-99. Review.

PMID: 15233728 [PubMed - indexed for MEDLINE]

13:

A new era in HIV vaccine development.

Lau CY, Velasco PP, Johnston MI.

Expert Rev Anti Infect Ther. 2007 Apr;5(2):205-15. Review.

PMID: 17402836 [PubMed - indexed for MEDLINE]

14:

Highlights of AIDS vaccine meeting.

Doepel LK.

NIAID AIDS Agenda. 1996 Mar:16-9.

PMID: 11363795 [PubMed - indexed for MEDLINE]

15:

Immunization update.

Mirza A, Rathore MH.

Adv Pediatr. 2007;54:135-71. Review.

PMID: 17918470 [PubMed - indexed for MEDLINE]

16:

Current progress in the development of HIV vaccines.

Spearman P.

Curr Pharm Des. 2006;12(9):1147-67. Review.

PMID: 16515492 [PubMed - indexed for MEDLINE]

18:

HIV vaccine development: lessons from the past and promise for the future.

Spearman P.

Curr HIV Res. 2003 Jan;1(1):101-20. Review.

PMID: 15043215 [PubMed - indexed for MEDLINE]

19:

Some statistical issues in the design of HIV-1 vaccine and treatment trials.

Gilbert PB.

Stat Methods Med Res. 2000 Jun;9(3):207-29. Review.

PMID: 11084705 [PubMed - indexed for MEDLINE]

20:

Vaccines and vaccine strategies against HIV.

Stratov I, DeRose R, Purcell DF, Kent SJ.

Curr Drug Targets. 2004 Jan;5(1):71-88. Review.

PMID: 14738219 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 101
of 6Next